Genetic testing and personalized ovarian cancer screening: a survey of public attitudes

Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial

(2014) Ranjit Manchanda et al.   JNCI-Journal of the National Cancer Institute

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing

(2014) Ranjit Manchanda et al.   JNCI-Journal of the National Cancer Institute

Angelina Jolie’s faulty gene: newspaper coverage of a celebrity’s preventive bilateral mastectomy in Canada, the United States and the United Kingdom

(2013) Kalina Kamenova et al.   GENETICS IN MEDICINE

The Angelina effect: immediate reach, grasp and impact of going public

(2013) Dina L.G. Borzekowski et al.   GENETICS IN MEDICINE

Incorporating genomics into breast and prostate cancer screening: assessing the implications

(2013) Susmita Chowdhury et al.   GENETICS IN MEDICINE

Public health implications from COGS and potential for risk stratification and screening

(2013) Hilary Burton et al.   NATURE GENETICS

Population-Based, Risk-Stratified Genetic Testing for Ovarian Cancer Risk: A Focus Group Study

(2013) S.F. Meisel et al.   Public Health Genomics

Stratified Cancer Screening: The Practicalities of Implementation

(2013) T. Dent et al.   Public Health Genomics

Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial

(2012) Paul F. Pinsky et al.   INTERNATIONAL JOURNAL OF CANCER

Genetic markers for ovarian cancer risk: are we close to seeing a clinical impact?

(2012) Patricia G Moorman   Personalized Medicine

Determinants of successful implementation of population-based cancer screening programmes

(2011) Elsebeth Lynge et al.   EUROPEAN JOURNAL OF CANCER

Effect of Screening on Ovarian Cancer Mortality

(2011) Saundra S. Buys   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Germline mutations in RAD51D confer susceptibility to ovarian cancer

(2011) Chey Loveday et al.   NATURE GENETICS

Mutations in BRIP1 confer high risk of ovarian cancer

(2011) Thorunn Rafnar et al.   NATURE GENETICS

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

(2010) Alfons Meindl et al.   NATURE GENETICS

Personal genomics and individual identities: motivations and moral imperatives of early users

(2010) Michelle L. McGowan et al.   NEW GENETICS AND SOCIETY

‘A Low Risk Is Still a Risk’: Exploring Women’s Attitudes towards Genetic Testing for Breast Cancer Susceptibility in Order to Target Disease Prevention

(2010) L. Henneman et al.   Public Health Genomics

Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)

(2009) Usha Menon et al.   LANCET ONCOLOGY